Higher Prevalence of Cancer in Patients with Diabetic Foot Syndrome

Chiara Goretti; Alessandro Prete; Alex Brocchi; Elisabetta Iacopi; Letizia Pieruzzi; Alberto Piaggesi

doi:10.3390/jcm13051448

Higher Prevalence of Cancer in Patients with Diabetic Foot Syndrome

J Clin Med. 2024 Mar 1;13(5):1448. doi: 10.3390/jcm13051448.

Authors

Chiara Goretti¹, Alessandro Prete², Alex Brocchi², Elisabetta Iacopi¹, Letizia Pieruzzi¹, Alberto Piaggesi¹

Affiliations

¹ Diabetic Foot Section, Department of Endocrinology and Metabolism, University of Pisa, 56126 Pisa, Italy.
² Diabetology Unit, Department of Endocrinology and Metabolism, University of Pisa, 56126 Pisa, Italy.

Abstract

Background: Diabetes mellitus (DM) is associated with a higher prevalence of many forms of cancer. Diabetic foot syndrome (DFS) is associated with higher risk of lower limb amputation and mortality not all explainable with a cardiovascular profile at greater risk compared with DM patients without DFS. DFS could be associated with an increasing cancer incidence. To explore a possible link between DFS and cancer, comparing two cohorts of patients (DFS+ and DFS-) with a cohort of superimposable non-DM controls. Methods: We retrospectively analysed the databases of our department for all consecutive patients admitted between January 2019 and December 2021, selecting all DM pts, and sorting DFS+ pts, admitted for foot complications, from DFS- ones, admitted for other reasons. Cases of pancreatic cancer as well as cancer-related admissions were excluded. Patients were compared to non-DM patients admitted for non-oncological medical problems. The primary endpoint was to compare the prevalence of cancer among the groups, while the secondary endpoint was to look for predictors for cancer in the groups studied. Results: A cohort of 445 consecutive DM inpatients (222 DFS+ and 223 DFS-) and 255 controls were studied. Cancer prevalence in DFS+ group was significantly higher than in DFS- (p = 0.008) and controls (p = 0.031), while no differences were observed between DFS- and the controls. Univariate regression analysis showed a significant association between cancer and DFS (p = 0.007), age at admission (p ≤ 0.001), years of diabetes (p = 0.017) and haemoglobin concentration [Hb] (p = 0.030). In the multivariate regression analysis with DFS, age at admission and [Hb], only DFS (p = 0.021) and age at admission (p ≤ 0.001) persisted as independent factors associated with cancer. Conclusions: A higher prevalence of cancer in DFS+ patients than in DFS- patients and non-diabetic controls is reported. DFS and age can both be considered independent predictors of cancer in patients with DM.

Keywords: cancer; comorbidities; death; diabetes; diabetic foot syndrome.

Grants and funding

This research received no external funding.